Related Experiment Video

Updated: Dec 19, 2025

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

11.0K

Tanshinone IIA inhibits osteosarcoma growth through modulation of AMPK-Nrf2 signaling pathway

Zengjun Xie1, Binbin He1, Ziyun Jiang1

  • 1Shenzhen Hospital of Guangzhou University of Chinese Medicine (Futian), Shenzhen, China.

Journal of Receptor and Signal Transduction Research
|June 5, 2020
PubMed

Insights

Tanshinone IIA (Tan IIA) effectively inhibits osteosarcoma cell survival, migration, and proliferation. This natural compound targets the AMPK/Nrf2 pathway, offering potential as an anticancer drug for bone tumors.

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • Osteosarcomas are primary malignant bone tumors.
  • Tanshinone IIA (Tan IIA) is a lipophilic compound from *Salvia miltiorrhiza* Bunge.
  • Understanding Tan IIA's effect on osteosarcoma is crucial for developing new treatments.

Purpose of the Study:

  • To investigate the role of Tan IIA in osteosarcoma cell survival, migration, and proliferation.
  • To elucidate the underlying molecular mechanisms involving the AMPK/Nrf2 signaling pathway.

Main Methods:

  • Cultured MG63 osteosarcoma cells *in vitro* and treated with varying Tan IIA concentrations.
  • Utilized ELISA, immunofluorescence, qPCR, and Western blots for molecular analysis.
  • Performed pathway analysis to confirm the role of AMPK/Nrf2 signaling.

Main Results:

  • Tan IIA dose-dependently inhibited osteosarcoma cell survival, migration, and proliferation.
  • Tan IIA reduced cell viability and inhibited transcription of migratory factors.
  • Tan IIA decreased AMPK and Nrf2 transcription and activity, which were critical for cell survival and proliferation.

Conclusions:

  • Tan IIA demonstrates significant anticancer effects against osteosarcoma cells.
  • The compound exerts its effects by modulating the AMPK/Nrf2 signaling pathway.
  • Tan IIA shows promise as a potential therapeutic agent for osteosarcoma treatment.
Keywords:
AMPKMG63 osteosarcoma cellNrf2Tan IIAmigration and proliferationsurvival

More Related Videos

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.5K
A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

4.1K

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.1K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.5K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
9.7K